In a controlled, third-party in vitro study, LifeVantage Corporation’s proprietary P84 formula was shown to hold strong biological activity in cellular pathways linked to gut regulation, repair and restoration. The study measured targeted gene expression and protein concentration using four gut cell types and examined 14 peptides and proteins known for their positive gut health properties.
The resulting research showed that P84 exceeded the threshold of being biologically meaningful across multiple targets and influenced gut wellness by calming overactive areas, properly processing fat and protein and repairing gut lining.
“These findings demonstrate that our proprietary P84 blend has a remarkable impact on activating key processes at the cellular level,” said Lisa Barnes, LifeVantage Vice President of R&D and Regulatory. “P84 reinforces LifeVantage’s position at the forefront of nutrigenomic innovation by positively influencing key markers necessary to ensure a strong, healthy gut. Gut health is at the root of so many things that impact people of all ages. It’s incredibly exciting to offer products that are unlike anything else, deliver meaningful change and create a lasting impact for consumers.”
P84 became part of the LifeVantage product portfolio last month during the company’s acquisition of the critical assets of LoveBiome.
The post New Study Shows LifeVantage P84 Positively Impacts Gut Health first appeared on Direct Selling News.
